Lanean...
Prospects for subunit vaccines: Technology advances resulting in efficacious antigens requires matching advances in early clinical trial investment
With the continued march of antimicrobial resistance, a renewed impetus for better vaccines has been heralded. Identification of potent subunit vaccines has been greatly facilitated by recent developments in reverse vaccinology and proteomics strategies. There are a range of antimicrobial resistant...
Gorde:
| Argitaratua izan da: | Hum Vaccin Immunother |
|---|---|
| Egile nagusia: | |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Taylor & Francis
2016
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5215456/ https://ncbi.nlm.nih.gov/pubmed/27494532 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2016.1216287 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|